✦ LIBER ✦

Adjuvant trastuzumab for breast cancer that overexpresses HER2?

Book ID: 120867180
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 155 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200112800-00026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant trastuzumab for HER2-positive b

Adjuvant trastuzumab for HER2-positive breast cancer

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

Trastuzumab Regimens for HER2-Overexpres

Trastuzumab Regimens for HER2-Overexpressing Metastatic Breast Cancer

✍ David R. Spigel; Harold J. Burstein 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB

Adjuvant Trastuzumab Therapy for HER2-Po

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

✍ Mohammad Jahanzeb 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Safety of adjuvant trastuzumab for HER-2

Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study

✍ Masataka Sawaki, Hirofumi Mukai, Nahomi Tokudome, Takahiro Nakayama, Naruto Tair 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 229 KB

Advances in the Adjuvant Treatment of HE

Advances in the Adjuvant Treatment of HER2-Overexpressing Breast Cancer with the Anti-HER2 Antibody Trastuzumab

✍ Chris Schwab; Joyce A. O'Shaughnessy 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 467 KB